• Fri, October 28, 2016

by: WOPRAI

Brista Corp (PINK:MYDX), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

Mind Solutions Inc. (OTC:VOIS), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

John Bean Technologies Corporation (NYSE:JBT), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outline

by: WOPRAI

Super Micro Computer, Inc. (NASDAQ:SMCI), Up By $2.34 (10.59%) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, Oc

by: WOPRAI

Hanesbrands Inc. (NYSE:HBI) Up By 13.45% ($3.21) From $23.860 After BUYINS.NET Report Predicted Strength After Earnings

by: WOPRAI

Whiting Petroleum Corporation (NYSE:WLL) Up By 5.81% ($0.50) From $8.610 After BUYINS.NET Report Predicted Strength After Earni

by: WOPRAI

Virtus Investment Partners Inc. (NASDAQ:VRTS), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outline

by: WOPRAI

STMicroelectronics NV (NYSE:STM), Up By $1.03 (12.77%) After BUYINS.NET SqueezeTrigger Report Released on Thursday, October 27t

by: WOPRAI

Otonomy Inc. (NASDAQ:OTIC), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

GenMark Diagnostics Inc. (NASDAQ:GNMK), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined I

by: WOPRAI

GREENGRO TECH (OTC:GRNH), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

QuinStreet Inc. (NASDAQ:QNST), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Rep

by: WOPRAI

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outline

by: WOPRAI

FormFactor Inc. (NASDAQ:FORM), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Rep

by: WOPRAI

Amgen Inc. (NASDAQ:AMGN) Down By 8.48% ($13.40) From $157.895 After BUYINS.NET Report Predicted Strength After Earnings

by: WOPRAI

Briggs & Stratton Corporation (NYSE:BGG) Down By 6.10% ($1.17) From $19.180 After BUYINS.NET Report Predicted Strength After Ea

by: WOPRAI

Gulf Island Fabrication Inc. (NASDAQ:GIFI) Down By 7.65% ($0.77) From $10.070 After BUYINS.NET Report Predicted Strength After

by: WOPRAI

Asantae Holdings International Inc (NASDAQ:JVA), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions O

by: WOPRAI

Calpine Corporation (NYSE:CPN), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Re

by: WOPRAI

Arrowhead Research Corporation (NASDAQ:ARWR), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outl

by: WOPRAI

SHOR SqueezeTrigger Price is $6.93. There is $6,087,505 That Short Sellers Still Need To Cover.

by: WOPRAI

ATRC SqueezeTrigger Price is $15.79. There is $47,628,013 That Short Sellers Still Need To Cover.

by: WOPRAI

AME SqueezeTrigger Price is $44.30. There is $191,655,720 That Short Sellers Still Need To Cover.

by: WOPRAI

BABY, FCCO, ADC, CNBKA, OLBK, Expected to Trade Higher After Bullish Insider Trading

by: WOPRAI

VICR, JNPR, PEBK, AIMC, SHAK, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

EGI, GLP, EUM, APU, SHY Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

PBIB, JBR, MPEL, USAT, BSV, CO Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

REED, AGG, MYRG, QUAD, CORE, DK Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

KW, VNQI, BITA, AAT, MUB, PCY Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

SPSC, PXR, OMCL, KIE, FXL, OESX Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

CHD, RSTI Expected To Be Up Before Next Earnings Releases

by: WOPRAI

CLMT Expected To Be Down Before Next Earnings Releases

by: WOPRAI

HMN, MPWR Expected To Be Down After Next Earnings Releases

by: WOPRAI

Matthew Kaplan Upgraded (UTHR) to Strong Buy on, Oct 28th, 2016

by: WOPRAI

Brian Brungardt Downgraded (AM) to Hold on, Oct 28th, 2016

by: WOPRAI

Jeff Kessler Downgraded (BCO) to Hold on, Oct 28th, 2016

by: WOPRAI

Robert Stallard Initiated (BA) at Hold on, Oct 28th, 2016

by: WOPRAI

Michael King Downgraded (AGEN) to Hold on, Oct 28th, 2016

by: WOPRAI

Eric Coldwell Downgraded (CAH) to Hold on, Oct 28th, 2016

by: WOPRAI

Stephen Bersey Initiated (TWLO) at Hold on, Oct 28th, 2016

by: WOPRAI

Anthony Stoss Downgraded (SYNA) to Hold on, Oct 28th, 2016

by: WOPRAI

Rajvindra Gill Downgraded (SYNA) to Hold on, Oct 28th, 2016

by: WOPRAI

Taylor Conrad Downgraded (TSCO) to Hold on, Oct 28th, 2016

by: WOPRAI

Michael Hoffman Upgraded (SRCL) to Strong Buy on, Oct 28th, 2016

by: WOPRAI

Tim Evans Upgraded (WST) to Buy on, Oct 28th, 2016

by: WOPRAI

Robert Stallard Initiated (TDG) at Strong Buy on, Oct 28th, 2016

by: WOPRAI

Chris Cooley Downgraded (TFX) to Hold on, Oct 28th, 2016

by: WOPRAI

Michael Gambardella Upgraded (CENX) to Hold on, Oct 28th, 2016

Matthew Kaplan Upgraded (UTHR) to Strong Buy on, Oct 28th, 2016

Matthew Kaplan of Ladenburg Thalmann, Upgraded "United Therapeutics Corporation" (UTHR) to Strong Buy on, Oct 28th, 2016.

Matthew has made no other calls on UTHR in the last 4 months.



There is 1 other peer that has a rating on UTHR. Out of the 1 peers that are also analyzing UTHR, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $129 on, Friday, July 29th, 2016